The study authors said they aimed to develop a robust and safe Crispr-Cas regimen, striving for an inclusive HIV cure for all that can inactivate diverse HIV strains across various cellular contexts.
Trending
- Food independence non-negotiable – Kyari
- Dentist stresses value of natural teeth
- Sultan calls for freedom to practise Islam without compulsion
- Stakeholders urge FG to cut farm production costs
- FG urged to prioritise infrastructure, R&D, local tech ownership
- Nigeria third in global youth well-being survey
- NEMA boosts flood response with USAR training
- SFPD targets 70,000 unimmunised children in Sokoto
